Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.


The Cure Starts Now has funded $30,229,360 USD in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 199 grants at over 100 hospitals in 29 countries.
Children's National Medical Center - $200,000
$200,000.00 USD
October 2017
Validation of TAK228 as an effective drug for treating children with DIPG
Ann & Robert H. Lurie Children's Hospital - $100,000
$100,000.00 USD
October 2017
Determine the efficacy of BMP and MEK inhibitors with RT to treat ACVR1 mutant DIPG
Anschutz Medical Campus - $50,000
$50,000.00 USD
September 2017
Toward a Multimodality Cure for DIPG: Investigation of Intratumoral Drug Penetration and Craniospinal Irradiation.
Massachusetts General Hospital - $50,000
$50,000.00 USD
September 2017
Repurposing Mefloquine for Diffuse Intrinsic Pontine Glioma Therapy
CONNECT Consortium - $893,678.37
$893,678.00 USD
September 2017
CONNECT (COllaborative Network for NEurooncology Clinical Trials) Consortium
University of Massachusetts Medical School - $50,000
$50,000.00 USD
May 2017
Advanced RNAi therapeutics for DIPG
Lucile Packard Children's Hospital Stanford - $50,000
$50,000.00 USD
May 2017
Cellular Cybercriminals: DIPG Hacks into the Neural Communication Infrastructure
Hospital for Sick Children - $50,000
$50,000.00 USD
September 2016
MRI Guided Focused Ultrasound: Targeted Drug Delivery in Diffuse Intrinsic Pontine Glioma
Gustave Roussy Cancer Center - $93,071
$93,071.00 USD
September 2016
Ultrasound-induced delivery of Panobinostat in preclinical models
The Hospital for Sick Children - $194,260
$194,260.00 USD
September 2016
Exploring the interactome of H3K27M to find therapeutic targets for DIPG
Cold Spring Harbor Laboratory - $100,000
$100,000.00 USD
September 2016
Allele-specific antisense therapy for DIPG
Children's Cancer Institute - $143,884 USD / $190,718 AUD (Approx)
$143,884.00 USD
September 2016
Radiosensitisation of Diffuse Intrinsic Pontine Gliomas by modulating the glucose metabolism
Dana-Farber Cancer Institute - $100,000
$100,000.00 USD
December 2015
Characterizing resistance mechanisms to radiation therapy and adjuvant chemotherapy in Diffuse Intrinsic Pontine Glioma
Cincinnati Children's Hospital Medical Center - $100,000
$100,000.00 USD
December 2015
An early Phase 2 Study of LEE011, a CDK4/6 Inhibitor, following radiation therapy in Children with Newly Diagnosed non-biopsied Diffuse Pontine Gliomas (DIPG) and Rb+ biopsied DIPG and High Grade Gliomas (HGG)
Baylor College of Medicine/Texas Children's Hospital - $200,000
$200,000.00 USD
December 2015
Targeting DIPGs through Super-activation of Steroid Receptor Co-activators: An in vivo Study in Patient-derived Intra-brain Stem Xenograft Mouse Models